SucroMate Equine, a drug developed by Louisville biotech firm CreoSalus, has been approved to aid in broodmare ovulation. The drug could save horse breeders time and money by reducing the need for a second trip to the breeding shed.
SucroMate Equine, a drug developed by Louisville biotech firm CreoSalus, has been approved to aid in broodmare ovulation. The drug could save horse breeders time and money by reducing the need for a second trip to the breeding shed.
SucroMate Equine, a drug developed by Louisville biotech firm CreoSalus, has been approved to aid in broodmare ovulation. The drug could save horse breeders time and money by reducing the need for a second trip to the breeding shed.